The highest estimate is 20.00. From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow OSTX.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
The current price of OSTX.BOATS is $1.38 USD — it has decreased by -2.13% in the past 24 hours. Watch OS Therapies stock price performance more closely on the chart.
What is OS Therapies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange OS Therapies stocks are traded under the ticker OSTX.BOATS.
What is OS Therapies market cap?▼
Today OS Therapies has the market capitalization of 48.6M
When is the next OS Therapies earnings date?▼
OS Therapies is going to release the next earnings report on April 06, 2026.
What were OS Therapies earnings last quarter?▼
OSTX.BOATS earnings for the last quarter are -0.21 USD per share, whereas the estimation was -0.12 USD resulting in a -71.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is OS Therapies revenue for the last year?▼
OS Therapies revenue for the last year amounts to 0 USD.
What is OS Therapies net income for the last year?▼
OSTX.BOATS net income for the last year is -21.77M USD.